Skip to content
Sign in

AGNG · NASDAQ · ETF

Global X Aging Population ETF (AGNG) Price, Holdings & Fees

$1,220.88+0.83%+$10.06End-of-day price as of Oct 9, 2026

Global X Aging Population ETF (AGNG) closed at $1,220.88 on Oct 9, 2026, up 0.83% from the previous close of $1,210.82.

Share price, past year

1Y +0.18%

52-week range $1,102.02 – $1,253.49. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$1,220.88
Sep 30, 2026$1,201.88
Aug 31, 2026$1,142.51
Jul 31, 2026$1,166.39
Jun 30, 2026$1,123.10
May 29, 2026$1,138.85
Apr 30, 2026$1,121.27
Mar 31, 2026$1,130.32
Feb 27, 2026$1,178.38
Jan 30, 2026$1,169.50
Dec 31, 2025$1,219.56
Nov 28, 2025$1,224.69
Oct 31, 2025$1,180.85

Key statistics

Expense ratio
0.50%
as of Mar 31, 2026
Net assets
$81.8M
as of May 31, 2026
Holdings
84
as of May 31, 2026
52-week range
$1,102.02 – $1,253.49

Global X Aging Population ETF's expense ratio is 0.50%: $50.00 a year on $10,000 invested.

Holdings

Global X Aging Population ETF held 84 investments worth $81.82M as of May 31, 2026. Its largest holding was NOVO NORDISK A/S, at 3.80% of the fund.

Global X Aging Population ETF largest holdings by share of net assets
#Holding% of fundValue
1NOVO NORDISK A/S3.80%$3.11M
2ELI LILLY AND COMPANY3.58%$2.93M
3EDWARDS LIFESCIENCES CORPORATION3.37%$2.76M
4Roche Holding AG3.21%$2.63M
5ABBVIE INC.3.16%$2.58M
6WELLTOWER INC.3.07%$2.51M
7VENTAS, INC.3.06%$2.51M
8MERCK & CO., INC.2.99%$2.45M
9BRISTOL-MYERS SQUIBB COMPANY2.98%$2.44M
10AMGEN INC.2.93%$2.40M
11JOHNSON & JOHNSON2.88%$2.35M
12UCB SA2.86%$2.34M
13ASTRAZENECA PLC2.80%$2.29M
14STRYKER CORPORATION2.78%$2.28M
15CHUGAI PHARMACEUTICAL CO., LTD.2.78%$2.28M
16Sandoz Group AG2.62%$2.14M
17MEDTRONIC PUBLIC LIMITED COMPANY2.60%$2.13M
18REGENERON PHARMACEUTICALS, INC.2.48%$2.03M
19BOSTON SCIENTIFIC CORPORATION2.44%$2.00M
20Alcon AG2.35%$1.92M
21BeOne Medicines AG2.24%$1.83M
22Celltrion, Inc.2.10%$1.71M
23DEXCOM, INC.2.01%$1.65M
24Astellas Pharma Inc.1.83%$1.50M
25UNITED THERAPEUTICS CORPORATION1.73%$1.41M

Top 25 of 84 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Global X Aging Population ETF holdings by asset type
Asset type% of fund
Stocks99.74%
Global X Aging Population ETF holdings by country, largest 10
Country% of fund
United States61.65%
Switzerland11.40%
Japan6.52%
Denmark5.92%
Hong Kong3.70%
Belgium3.35%
South Korea2.10%
Canada0.96%
United Kingdom0.90%
Germany0.90%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, Global X Aging Population ETF's total return was −8.35%, as reported to the SEC.

Global X Aging Population ETF monthly total returns
MonthTotal return
May 31, 2026−7.59%
Apr 30, 2026−0.82%
Mar 31, 20260.00%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Global X Aging Population ETF
Ticker
AGNG
Exchange
NASDAQ
Fund type
ETF
Trust
Global X Funds
SEC series ID
S000054162
SEC CIK
0001432353
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by Global X Funds, the trust behind Global X Aging Population ETF, and cover all of its funds.

Frequently asked questions

What is AGNG's price?

Global X Aging Population ETF (AGNG) closed at $1,220.88 on Oct 9, 2026, up 0.83% from the previous close of $1,210.82.

What is AGNG's expense ratio?

Global X Aging Population ETF's expense ratio is 0.50%: $50.00 a year on $10,000 invested.

What does AGNG hold?

Global X Aging Population ETF held 84 investments worth $81.82M as of May 31, 2026. Its largest holding was NOVO NORDISK A/S, at 3.80% of the fund. Its five largest holdings were NOVO NORDISK A/S, ELI LILLY AND COMPANY, EDWARDS LIFESCIENCES CORPORATION, Roche Holding AG, ABBVIE INC..

How has AGNG performed?

Over the 3 months to May 31, 2026, Global X Aging Population ETF's total return was −8.35%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 29, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Mar 31, 2026. Prices are generated sample data for development. Data sources and disclosures